Picture of CTI Biopharma logo

CTIC — CTI Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: CTI Biopharma Reports Second Quarter 2020 Financial Results

Aug 6 (Reuters) - CTI Biopharma Corp  CTIC.O :
    * CTI BIOPHARMA REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.19
    * NO REVENUES WERE RECOGNIZED FOR THREE AND SIX MONTHS ENDED
JUNE
30, 2020
    * EXPECT CURRENT CASH AND CASH EQUIVALENTS WILL ENABLE US TO
FUND
OPERATIONS INTO Q4 OF 2021

Source text for Eikon:  ID:nPn9d5cyya 
Further company coverage:  CTIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on CTI Biopharma

See all news